EUVIMEDEUVIMED entdecken
Crossref

Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways

Ahmed M El-Dessouki, Amany A Alzokaky, Nahed A Raslan, Samar Ibrahim, Heba Mohammed Refat M Selim, Ahmed A Al-Karmalawy

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03567-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Ahmed M El-Dessouki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, 12566, Giza, Egypt. ahmed.desoky@a…. Hauptthemen laut MEDLINE: Dabigatran, Methotrexate, Chemical and Drug Induced Liver Injury, Antithrombins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DabigatranMethotrexateChemical and Drug Induced Liver InjuryAntithrombinsAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinMaleNF-kappa BSignal TransductionToll-Like Receptor 4RatsInterleukin-1betaBlood CoagulationChemokine CCL2Oxidative StressLiverRats, WistarEndothelium, Vascular

Stichwörter der Autor:innen

CoagulationDabigatranEndothelial dysfunctionHepatotoxicityInflammationMethotrexate

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinDabigatranMethotrexateNF-kappa BNlrp3 protein, ratToll-Like Receptor 4Tlr4 protein, ratInterleukin-1betaChemokine CCL2Antithrombins

Autor:innen und Institutionen

  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th of October City, 12566, Giza, Egypt. ahmed.desoky@acu.edu.eg.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, 11651, Egypt.
  • Pharmacology and Biochemistry Department, Faculty of Pharmacy, Horus University, New Damietta, 34518, Egypt.
  • Clinical Pharmacy Department, College of Health Sciences and Nursing, Al-Rayan Colleges, AL-Madinah AL-Munawarah, Saudi Arabia.
  • Pharmacy Practice and Clinical Pharmacy Department, Faculty of Pharmacy, Galala University-Ataka, Suez, Egypt.
  • Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, 11597, Riyadh, Saudi Arabia.

Zitieren

APA

El-Dessouki, A. M., Alzokaky, A. A., Raslan, N. A., Ibrahim, S., Selim, H. M. R. M., & Al-Karmalawy, A. A. (2025). Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03567-w

Vancouver

El-Dessouki AM, Alzokaky AA, Raslan NA, Ibrahim S, Selim HMRM, Al-Karmalawy AA. Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03567-w

BibTeX
@article{ElDessouki2025,
  author = {El-Dessouki, Ahmed M and Alzokaky, Amany A and Raslan, Nahed A and Ibrahim, Samar and Selim, Heba Mohammed Refat M and Al-Karmalawy, Ahmed A},
  title = {Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03567-w}
}
Kostenlos starten →